D-0374-2022 Class II Terminated

Recalled by Ingenus Pharmaceuticals Llc — Orlando, FL

FDA drug recall D-0374-2022 was initiated by Ingenus Pharmaceuticals Llc on Jan 10, 2022 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Aug 15, 2023). Affected quantity: 45,173 cans.

Recall details

Product Type
Drugs
Report Date
Jan 26, 2022
Initiation Date
Jan 10, 2022
Termination Date
Aug 15, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
45,173 cans

Product description

Clobetasol Propionate Foam, 0.05%, packaged in a) 50 g can (NDC 50742-304-50), and b) 100 g can (NDC 50742-304-01), Rx only, Manufactured for: Ingenus Pharmaceuticals, LLC, Orlando, FL 32839-6408.

Reason for recall

CGMP Deviations

Distribution pattern

Nationwide in the USA

Code information

a) Lots: 32921 Exp. 06/2022; 33152 Exp. 08/2022; 33340 Exp. 11/2022; b) Lots: 33152 Exp. 08/2022; 33340 Exp. 11/2022.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0374-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0374-2022. Report a data issue: hello@regdatalab.com.